TEST BANK $sf
Pharmacology Illustrated Reviews
$sf $sf
8th Edition Whalen Test Bank
$sf $sf $sf $sf
TEST BANK $sf
, Pharmacology $sfIllustrated $sfReviews $sf8th $sfEdition $sfWhalen $sfTest $sfBank
$sf TABLE $sfOF $sfCONTENT
Chapter $sf1: $sfPharmacokinetics
Chapter $sf2: $sfDrug–Receptor $sfInteractions $sfand $sfPharmacodynamics
Chapter $sf3: $sfThe $sfAutonomic $sfNervous $sfSystem
Chapter $sf4: $sfCholinergic $sfAgonists
Chapter $sf5: $sfCholinergic $sfAntagonists
Chapter $sf6: $sfAdrenergic $sfAgonists
Chapter $sf7: $sfAdrenergic $sfAntagonists
Chapter $sf8: $sfDrugs $sffor $sfNeurodegenerative $sfDiseases
Chapter $sf9: $sfAnxiolytic $sfand $sfHypnotic $sfDrugs
Chapter $sf10: $sfAntidepressants
Chapter $sf11: $sfAntipsychotic $sfDrugs
Chapter $sf12: $sfDrugs $sffor $sfEpilepsy
Chapter $sf13: $sfAnesthetics
Chapter $sf14: $sfOpioids
Chapter $sf15: $sfDrugs $sfof $sfAbuse
Chapter $sf16: $sfCNS $sfStimulants
Chapter $sf17: $sfAntihypertensives
Chapter $sf18: $sfDiuretics
Chapter $sf19: $sfHeart $sfFailure
Chapter $sf20: $sfAntiarrhythmics
Chapter $sf21: $sfAntianginal $sfDrugs
Chapter $sf22: $sfAnticoagulants $sfand $sfAntiplatelet $sfAgents
Chapter $sf23: $sfDrugs $sffor $sfHyperlipidemia
Chapter $sf24: $sfPituitary $sfand $sfThyroid
Chapter $sf25: $sfDrugs $sffor $sfDiabetes
Chapter $sf26: $sfEstrogens $sfand $sfAndrogens
Chapter $sf27: $sfAdrenal $sfHormones
Chapter $sf28: $sfDrugs $sffor $sfObesity
Chapter $sf29: $sfDrugs $sffor $sfDisorders $sfof $sfthe $sfRespiratory $sfSystem
Chapter $sf30: $sfAntihistamines
Chapter $sf31: $sfGastrointestinal $sfand $sf Antiemetic $sfDrugs
Chapter $sf32: $sfDrugs $sffor $sfUrologic $sfDisorders
Chapter $sf33: $sfDrugs $sffor $sfAnemia
Chapter $sf34: $sfDrugs $sffor $sfDermatologic $sfDisorders
Chapter $sf35: $sfDrugs $sffor $sfBone $sfDisorders
Chapter $sf36: $sfAnti-inflammatory, $sf Antipyretic, $sfand $sf Analgesic $sf Agents
Chapter $sf37: $sfPrinciples $sfof $sfAntimicrobial $sfTherapy
Chapter $sf38: $sfCell $sfWall $sfInhibitors
Chapter $sf39: $sfProtein $sfSynthesis $sfInhibitors
Chapter $sf40: $sfQuinolones, $sfFolic $sfAcid $sfAntagonists, $sfand $sfUrinary $sfTract $sfAntiseptics
Chapter $sf41: $sfAntimycobacterial $sf Drugs
Chapter $sf42: $sfAntifungal $sfDrugs
Chapter $sf43: $sfAntiprotozoal $sfDrugs
Chapter $sf44: $sfAnthelmintic $sfDrugs
Chapter $sf45: $sfAntiviral $sfDrugs
Chapter $sf46: $sfAnticancer $sfDrugs
Chapter $sf47: $sfImmunosuppressants
Chapter $sf48: $sfClinical $sfToxicology
, Page $sf1 $sfof $sf507
Pharmacology $sfIllustrated $sfReviews $sf8th $sfEdition
Whalen $sfTest $sfBank
$sf
Chapter $sf1:
Pharmacokinetics
$sf
$sf MULTIPLE $sfCHOICE
1. Which $sfdrugs $sfwill $sfgo $sfthrough $sfa $sfpharmaceutic $sfphase $sfafter $sfit $sf is $sfadministered?
a. Intramuscular $sfcephalosporins
b. Intravenous $sfvasopressors
c. Oral $sfanalgesics
d. Subcutaneous
antiglycemics $sfANS: $sfC
$sf
When $sfdrugs $sfare $sfadministered $sfparenterally, $sfthere $sfis $sfno $sfpharmaceutic $sfphase, $sfwhich $sfoccurs
when $sfa $sfdrug $sfbecomes $sfa $sfsolution $sfthat $sfcan $sfcross $sfthe $sfbiologic $sfmembrane.
$sf
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfAssessment
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
2. The $sfnurse $sfis $sfpreparing $sfto $sfadminister $sfan $sforal $sfmedication $sfand $sfwants $sfto $sfensure $sfa
$sf rapid $sfdrug $sfaction. $sfWhich $sfform $sfof $sfthe $sfmedication $sfwill $sfthe $sfnurse $sfadminister?
a. Capsule
b. Enteric-coated $sfpill
c. Liquid $sfsuspension
d. Tablet
$sf ANS:
$sf C
Liquid $sfdrugs $sfare $sfalready $sfin $sfsolution, $sfwhich $sfis $sfthe $sfform $sfnecessary $sffor $sfabsorption $sfin
$sf the $sfGI$sftract. $sfThe $sfother $sfforms $sfmust $sfdisintegrate $sfinto $sfsmall $sfparticles $sfand $sfthen
$sf dissolve $sfbefore $sfbeing $sfabsorbed.
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfNursing $sfIntervention
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
Page $sf1 $sfof
$sf507
, Stuvia.com $sf- $sfThe $sfMarketplace $sfto $sfBuy $sfand $sfSell
$sfyour $sfStudy
3. The $sfnurse $sfis $sfteaching $sfa $sfpatient $sfwho $sfwill $sfbe $sfdischarged $sfhome $sfwith $sfa $sfprescription $sffor
an $sfenteric- $sfcoated $sftablet. $sfWhich $sfstatement $sfby $sfthe $sfpatient $sfindicates $sfunderstanding $sfof
$sf
$sf the $sfteaching?
a. I $sfmay $sfcrush $sfthe $sftablet $sf and $sfput $sfit $sfin $sfapplesauce $sfto $sfimprove $sfabsorption.
b. I $sfshould $sfconsume $sfacidic $sf foods $sfto $sfenhance $sfabsorption $sfof $sfthis $sfmedication.
c. I$sfshould $sfexpect $sf a $sfdelay $sfin $sfonset $sfof $sfthe $sfdrugs $sfeffects $sfafter $sftaking $sfthe $sftablet.
d. I $sfshould $sftake $sfthis $sfmedication $sfwith $sfhigh-fat $sffoods $sfto $sfimprove $sfits
action. $sfANS: $sfC
$sf
Enteric-coated $sftablets $sfresist $sfdisintegration $sfin $sfthe $sfacidic $sfenvironment $sfof $sfthe $sfstomach
$sf and $sfdisintegrate $sfwhen $sfthey $sfreach $sfthe $sfsmall $sfintestine. $sfThere $sfis $sfusually $sfsome $sfdelay $sfin
$sf onset $sfof $sfactions $sfafter $sftaking $sfthese $sfmedications. $sfEnteric-coated $sftablets $sfshould $sfnot $sfbe
$sf crushed $sfor $sfchewed, $sfwhich $sfwould $sfalter $sfthe $sftime $sfand $sflocation $sfof $sfabsorption. $sfAcidic
$sf foods $sfwill $sfnot $sfenhance $sfthe $sfabsorption $sfof $sfthe $sfmedication. $sfThe $sfpatient $sfshould $sfnot $sfto
$sf eat $sfhigh-fat $sffood $sfbefore $sfingesting $sfan $sfenteric-coated $sftablet, $sfbecause $sfhigh-fat $sffoods
$sf decrease $sfthe $sfabsorption $sfrate.
DIF: $sfCOGNITIVE $sfLEVEL: $sfApplying $sf(Application) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfNursing $sfIntervention
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
4. A $sfpatient $sfwho $sfis $sfnewly $sfdiagnosed $sfwith $sftype $sf1 $sfdiabetes $sfmellitus $sfasks $sfwhy $sfinsulin
$sf must $sfbe $sfgiven $sfby $sfsubcutaneous $sfinjection $sfinstead $sfof $sfby$sfmouth. $sfThe $sfnurse $sfwill $sfexplain
$sf that $sfthis $sfis $sfbecause
a. absorption $sfis $sfdiminished $sfby $sfthe $sffirst-pass $sfeffects $sfin $sfthe $sfliver.
b. absorption $sfis $sffaster $sfwhen $sfinsulin $sfis $sfgiven $sfsubcutaneously.
c. digestive $sfenzymes $sfin $sfthe $sfgastrointestinal $sftract $sfprevent $sfabsorption.
d. the $sforal $sfform $sfis $sfless $sfpredictable $sfwith $sfmore $sfadverse
effects. $sfANS: $sfC
$sf
Insulin, $sfgrowth $sfhormones, $sfand $sfother $sfprotein-based $sfdrugs $sfare $sfdestroyed $sfin $sfthe $sfsmall
$sf intestine $sfby $sfdigestive $sfenzymes $sfand $sfmust $sfbe $sfgiven $sfparenterally. $sfBecause $sfinsulin $sfis
$sf destroyed $sfby $sfdigestive $sfenzymes, $sfit $sfwould $sfnot $sfmake $sfit $sfto $sfthe $sfliver $sffor $sfmetabolism $sfwith
$sf a $sffirst-pass $sfeffect. $sfSubcutaneous $sftissue $sfhas $sffewer $sfblood $sfvessels, $sfso $sfabsorption $sfis
$sf slower $sfin $sfsuch $sftissue. $sfInsulin $sfis $sfgiven $sfsubcutaneously $sfbecause $sfit $sfis $sfdesirable $sfto $sfhave
$sf it $sfabsorb $sfslowly.
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
Page $sf2 $sfof
$sf507
Pharmacology Illustrated Reviews
$sf $sf
8th Edition Whalen Test Bank
$sf $sf $sf $sf
TEST BANK $sf
, Pharmacology $sfIllustrated $sfReviews $sf8th $sfEdition $sfWhalen $sfTest $sfBank
$sf TABLE $sfOF $sfCONTENT
Chapter $sf1: $sfPharmacokinetics
Chapter $sf2: $sfDrug–Receptor $sfInteractions $sfand $sfPharmacodynamics
Chapter $sf3: $sfThe $sfAutonomic $sfNervous $sfSystem
Chapter $sf4: $sfCholinergic $sfAgonists
Chapter $sf5: $sfCholinergic $sfAntagonists
Chapter $sf6: $sfAdrenergic $sfAgonists
Chapter $sf7: $sfAdrenergic $sfAntagonists
Chapter $sf8: $sfDrugs $sffor $sfNeurodegenerative $sfDiseases
Chapter $sf9: $sfAnxiolytic $sfand $sfHypnotic $sfDrugs
Chapter $sf10: $sfAntidepressants
Chapter $sf11: $sfAntipsychotic $sfDrugs
Chapter $sf12: $sfDrugs $sffor $sfEpilepsy
Chapter $sf13: $sfAnesthetics
Chapter $sf14: $sfOpioids
Chapter $sf15: $sfDrugs $sfof $sfAbuse
Chapter $sf16: $sfCNS $sfStimulants
Chapter $sf17: $sfAntihypertensives
Chapter $sf18: $sfDiuretics
Chapter $sf19: $sfHeart $sfFailure
Chapter $sf20: $sfAntiarrhythmics
Chapter $sf21: $sfAntianginal $sfDrugs
Chapter $sf22: $sfAnticoagulants $sfand $sfAntiplatelet $sfAgents
Chapter $sf23: $sfDrugs $sffor $sfHyperlipidemia
Chapter $sf24: $sfPituitary $sfand $sfThyroid
Chapter $sf25: $sfDrugs $sffor $sfDiabetes
Chapter $sf26: $sfEstrogens $sfand $sfAndrogens
Chapter $sf27: $sfAdrenal $sfHormones
Chapter $sf28: $sfDrugs $sffor $sfObesity
Chapter $sf29: $sfDrugs $sffor $sfDisorders $sfof $sfthe $sfRespiratory $sfSystem
Chapter $sf30: $sfAntihistamines
Chapter $sf31: $sfGastrointestinal $sfand $sf Antiemetic $sfDrugs
Chapter $sf32: $sfDrugs $sffor $sfUrologic $sfDisorders
Chapter $sf33: $sfDrugs $sffor $sfAnemia
Chapter $sf34: $sfDrugs $sffor $sfDermatologic $sfDisorders
Chapter $sf35: $sfDrugs $sffor $sfBone $sfDisorders
Chapter $sf36: $sfAnti-inflammatory, $sf Antipyretic, $sfand $sf Analgesic $sf Agents
Chapter $sf37: $sfPrinciples $sfof $sfAntimicrobial $sfTherapy
Chapter $sf38: $sfCell $sfWall $sfInhibitors
Chapter $sf39: $sfProtein $sfSynthesis $sfInhibitors
Chapter $sf40: $sfQuinolones, $sfFolic $sfAcid $sfAntagonists, $sfand $sfUrinary $sfTract $sfAntiseptics
Chapter $sf41: $sfAntimycobacterial $sf Drugs
Chapter $sf42: $sfAntifungal $sfDrugs
Chapter $sf43: $sfAntiprotozoal $sfDrugs
Chapter $sf44: $sfAnthelmintic $sfDrugs
Chapter $sf45: $sfAntiviral $sfDrugs
Chapter $sf46: $sfAnticancer $sfDrugs
Chapter $sf47: $sfImmunosuppressants
Chapter $sf48: $sfClinical $sfToxicology
, Page $sf1 $sfof $sf507
Pharmacology $sfIllustrated $sfReviews $sf8th $sfEdition
Whalen $sfTest $sfBank
$sf
Chapter $sf1:
Pharmacokinetics
$sf
$sf MULTIPLE $sfCHOICE
1. Which $sfdrugs $sfwill $sfgo $sfthrough $sfa $sfpharmaceutic $sfphase $sfafter $sfit $sf is $sfadministered?
a. Intramuscular $sfcephalosporins
b. Intravenous $sfvasopressors
c. Oral $sfanalgesics
d. Subcutaneous
antiglycemics $sfANS: $sfC
$sf
When $sfdrugs $sfare $sfadministered $sfparenterally, $sfthere $sfis $sfno $sfpharmaceutic $sfphase, $sfwhich $sfoccurs
when $sfa $sfdrug $sfbecomes $sfa $sfsolution $sfthat $sfcan $sfcross $sfthe $sfbiologic $sfmembrane.
$sf
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfAssessment
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
2. The $sfnurse $sfis $sfpreparing $sfto $sfadminister $sfan $sforal $sfmedication $sfand $sfwants $sfto $sfensure $sfa
$sf rapid $sfdrug $sfaction. $sfWhich $sfform $sfof $sfthe $sfmedication $sfwill $sfthe $sfnurse $sfadminister?
a. Capsule
b. Enteric-coated $sfpill
c. Liquid $sfsuspension
d. Tablet
$sf ANS:
$sf C
Liquid $sfdrugs $sfare $sfalready $sfin $sfsolution, $sfwhich $sfis $sfthe $sfform $sfnecessary $sffor $sfabsorption $sfin
$sf the $sfGI$sftract. $sfThe $sfother $sfforms $sfmust $sfdisintegrate $sfinto $sfsmall $sfparticles $sfand $sfthen
$sf dissolve $sfbefore $sfbeing $sfabsorbed.
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfNursing $sfIntervention
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
Page $sf1 $sfof
$sf507
, Stuvia.com $sf- $sfThe $sfMarketplace $sfto $sfBuy $sfand $sfSell
$sfyour $sfStudy
3. The $sfnurse $sfis $sfteaching $sfa $sfpatient $sfwho $sfwill $sfbe $sfdischarged $sfhome $sfwith $sfa $sfprescription $sffor
an $sfenteric- $sfcoated $sftablet. $sfWhich $sfstatement $sfby $sfthe $sfpatient $sfindicates $sfunderstanding $sfof
$sf
$sf the $sfteaching?
a. I $sfmay $sfcrush $sfthe $sftablet $sf and $sfput $sfit $sfin $sfapplesauce $sfto $sfimprove $sfabsorption.
b. I $sfshould $sfconsume $sfacidic $sf foods $sfto $sfenhance $sfabsorption $sfof $sfthis $sfmedication.
c. I$sfshould $sfexpect $sf a $sfdelay $sfin $sfonset $sfof $sfthe $sfdrugs $sfeffects $sfafter $sftaking $sfthe $sftablet.
d. I $sfshould $sftake $sfthis $sfmedication $sfwith $sfhigh-fat $sffoods $sfto $sfimprove $sfits
action. $sfANS: $sfC
$sf
Enteric-coated $sftablets $sfresist $sfdisintegration $sfin $sfthe $sfacidic $sfenvironment $sfof $sfthe $sfstomach
$sf and $sfdisintegrate $sfwhen $sfthey $sfreach $sfthe $sfsmall $sfintestine. $sfThere $sfis $sfusually $sfsome $sfdelay $sfin
$sf onset $sfof $sfactions $sfafter $sftaking $sfthese $sfmedications. $sfEnteric-coated $sftablets $sfshould $sfnot $sfbe
$sf crushed $sfor $sfchewed, $sfwhich $sfwould $sfalter $sfthe $sftime $sfand $sflocation $sfof $sfabsorption. $sfAcidic
$sf foods $sfwill $sfnot $sfenhance $sfthe $sfabsorption $sfof $sfthe $sfmedication. $sfThe $sfpatient $sfshould $sfnot $sfto
$sf eat $sfhigh-fat $sffood $sfbefore $sfingesting $sfan $sfenteric-coated $sftablet, $sfbecause $sfhigh-fat $sffoods
$sf decrease $sfthe $sfabsorption $sfrate.
DIF: $sfCOGNITIVE $sfLEVEL: $sfApplying $sf(Application) $sfREF: $sfdm $sf3
$sf TOP: $sfNURSING $sfPROCESS: $sfNursing $sfIntervention
MSC: $sfNCLEX: $sfPhysiological $sfIntegrity: $sfPharmacological $sfand $sfParenteral $sfTherapies
4. A $sfpatient $sfwho $sfis $sfnewly $sfdiagnosed $sfwith $sftype $sf1 $sfdiabetes $sfmellitus $sfasks $sfwhy $sfinsulin
$sf must $sfbe $sfgiven $sfby $sfsubcutaneous $sfinjection $sfinstead $sfof $sfby$sfmouth. $sfThe $sfnurse $sfwill $sfexplain
$sf that $sfthis $sfis $sfbecause
a. absorption $sfis $sfdiminished $sfby $sfthe $sffirst-pass $sfeffects $sfin $sfthe $sfliver.
b. absorption $sfis $sffaster $sfwhen $sfinsulin $sfis $sfgiven $sfsubcutaneously.
c. digestive $sfenzymes $sfin $sfthe $sfgastrointestinal $sftract $sfprevent $sfabsorption.
d. the $sforal $sfform $sfis $sfless $sfpredictable $sfwith $sfmore $sfadverse
effects. $sfANS: $sfC
$sf
Insulin, $sfgrowth $sfhormones, $sfand $sfother $sfprotein-based $sfdrugs $sfare $sfdestroyed $sfin $sfthe $sfsmall
$sf intestine $sfby $sfdigestive $sfenzymes $sfand $sfmust $sfbe $sfgiven $sfparenterally. $sfBecause $sfinsulin $sfis
$sf destroyed $sfby $sfdigestive $sfenzymes, $sfit $sfwould $sfnot $sfmake $sfit $sfto $sfthe $sfliver $sffor $sfmetabolism $sfwith
$sf a $sffirst-pass $sfeffect. $sfSubcutaneous $sftissue $sfhas $sffewer $sfblood $sfvessels, $sfso $sfabsorption $sfis
$sf slower $sfin $sfsuch $sftissue. $sfInsulin $sfis $sfgiven $sfsubcutaneously $sfbecause $sfit $sfis $sfdesirable $sfto $sfhave
$sf it $sfabsorb $sfslowly.
DIF: $sfCOGNITIVE $sfLEVEL: $sfUnderstanding $sf(Comprehension) $sfREF: $sfdm $sf3
Page $sf2 $sfof
$sf507
